The Ervebo vaccine has proved safe and effective against the more common Zaire strain of the Ebola virus, and World Health Organization experts say early data, notably from animal trials, suggest it may also offer some protection against the rarer Bundibugyo strain, which is spreading in the DR Congo. We discuss this with our guest, Dr. Paulin Mutombo Beya, deputy director at the Kinshasa School of Public Health.